Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08UQU
|
||||
| Former ID |
DNC013522
|
||||
| Drug Name |
(R)-(-)-2-methoxy-11-hydroxyaporphine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529289] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C18H19NO2
|
||||
| Canonical SMILES |
CN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=CC=C4)O
|
||||
| InChI |
1S/C18H19NO2/c1-19-7-6-12-8-13(21-2)10-14-17(12)15(19)9-11-4-3-5-16(20)18(11)14/h3-5,8,10,15,20H,6-7,9H2,1-2H3/t15-/m1/s1
|
||||
| InChIKey |
UGNGRDRWDHJJJI-OAHLLOKOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | D(2) dopamine receptor | Target Info | Inhibitor | [529289] | |
| Dopamine D1 receptor | Target Info | Inhibitor | [529289] | ||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Dopamine receptor mediated signaling pathway | |||||
| Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
| PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.